|
|
||||||||








* Division of Rheumatology, Allergy, and Clinical Immunology, and
Department of Chemistry, University of California, Davis, CA 95616;
University of California Davis Cancer Center, Division of Hematology and Oncology, Department of Internal Medicine, University of California at Davis, Sacramento, CA 95817;
Division of Gastroenterology and Hepatology, Department of Internal Medicine, Jikei University School of Medicine, Tokyo, Japan;
¶ Department of Pathology, Emory University, Atlanta, GA 30322; and
|| Department of Microbiology, Monash University, Clayton, Victoria, Australia
Previous work has demonstrated that immunization of rabbits with the xenobiotic 6-bromohexanoate coupled to BSA breaks tolerance and induces autoantibodies to mitochondria in rabbits. Such immunized rabbits develop high-titer Abs to pyruvate dehydrogenase complex (PDC)-E2, the major autoantigen of primary biliary cirrhosis. In efforts to map the fine specificity of these autoantibodies, rabbits were immunized biweekly with 6-bromohexanoate-BSA and screened for reactivity using a unique xenobiotic-peptide-agarose microarray platform with an emphasis on identifying potential structures that mimic the molecular image formed by the association of lipoic acid with the immunodominant PDC-E2 peptide. Essentially, a total of 23 xenobiotics and lipoic acid were coupled to the 12-mer peptide backbones, PDC, a mutant PDC, and albumin. As expected, we succeeded in breaking tolerance using this small organic molecule coupled to BSA. However, unlike multiple experimental methods of breaking tolerance, we report in this study that, following continued immunization, the rabbits recover tolerance. With repeated immunization, the response to the rPDC-E2 protein increased with a gradual reduction in autoantibodies against the lipoic acid-peptide, i.e., the primary tolerance-breaking autoantigen. Detailed analysis of this system may provide strategies on how to restore tolerance in patients with autoimmune disease.
This article has been cited by other articles:
![]() |
A. Kawano, S. Shimoda, T. Kamihira, F. Ishikawa, H. Niiro, Y. Soejima, A. Taketomi, Y. Maehara, M. Nakamura, A. Komori, et al. Peripheral Tolerance and the Qualitative Characteristics of Autoreactive T Cell Clones in Primary Biliary Cirrhosis J. Immunol., September 1, 2007; 179(5): 3315 - 3324. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. S. C. Leung, O. Park, K. Tsuneyama, M. J. Kurth, K. S. Lam, A. A. Ansari, R. L. Coppel, and M. E. Gershwin Induction of Primary Biliary Cirrhosis in Guinea Pigs following Chemical Xenobiotic Immunization J. Immunol., August 15, 2007; 179(4): 2651 - 2657. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. M. Kaplan and M. E. Gershwin Primary Biliary Cirrhosis N. Engl. J. Med., September 22, 2005; 353(12): 1261 - 1273. [Full Text] [PDF] |
||||
![]() |
K. Amano, P. S. C. Leung, R. Rieger, C. Quan, X. Wang, J. Marik, Y. F. Suen, M. J. Kurth, M. H. Nantz, A. A. Ansari, et al. Chemical Xenobiotics and Mitochondrial Autoantigens in Primary Biliary Cirrhosis: Identification of Antibodies against a Common Environmental, Cosmetic, and Food Additive, 2-Octynoic Acid J. Immunol., May 1, 2005; 174(9): 5874 - 5883. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |